Literature DB >> 20960046

Comparison of the replication properties of murine and human calicivirus RNA-dependent RNA polymerases.

Rowena A Bull1, Jennifer Hyde, Jason M Mackenzie, Grant S Hansman, Tomoichiro Oka, Naokazu Takeda, Peter A White.   

Abstract

The human caliciviruses (CV), norovirus (NoV) and sapovirus (SaV), are major causes of outbreak gastroenteritis worldwide. To date, the investigation of human NoV and SaV replication cycles has been impeded as neither is culturable. Consequently, the recently discovered murine NoV (MNV) has been adopted as a surrogate replication model for the human CVs. In this study, we sought to compare the biochemical properties of the MNV RNA-dependent RNA polymerase (RdRp) with related human NoV and SaV-RdRps to address the suitability of MNV as a model for the human CVs. Three human NoV-RdRps (GII.b, GII.4 and GII.7), an MNV-RdRp and two human SaV-RdRps (GI and GII) were overexpressed in Escherichia coli, purified and their enzymatic activity and fidelity compared. Despite ~70% amino acid variation between the RdRp from the two different CV genera, the majority of the physiological characteristics of the RdRps were similar. All RdRps exhibited co-operative dimerisation and had optimal activity at 25°C, a pH range between 7 and 8, required 2-5 mM MnCl(2) and were inhibited with increasing NaCl concentrations. We observed RdRp activity at temperatures as low as 5°C and as high as 65°C. Using an in vitro fidelity assay, similar mutation rates were observed for the separate RdRps (1 × 10(-4)-1 × 10(-5)). This is the first report to compare the physiological, biochemical and mutational properties of the MNV-RdRp to those of the human CV-RdRps and it suggests that MNV may be directly applicable to the study of human NoV.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960046     DOI: 10.1007/s11262-010-0535-y

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  44 in total

1.  Increasing the precision of comparative models with YASARA NOVA--a self-parameterizing force field.

Authors:  Elmar Krieger; Günther Koraimann; Gert Vriend
Journal:  Proteins       Date:  2002-05-15

2.  Norovirus proteinase-polymerase and polymerase are both active forms of RNA-dependent RNA polymerase.

Authors:  Gaël Belliot; Stanislav V Sosnovtsev; Kyeong-Ok Chang; Vijay Babu; Uzo Uche; Jamie J Arnold; Craig E Cameron; Kim Y Green
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Protein-primed and de novo initiation of RNA synthesis by norovirus 3Dpol.

Authors:  Jacques Rohayem; Ivonne Robel; Katrin Jäger; Ulrike Scheffler; Wolfram Rudolph
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 4.  The epidemiologic and clinical importance of norovirus infection.

Authors:  Robert L Atmar; Mary K Estes
Journal:  Gastroenterol Clin North Am       Date:  2006-06       Impact factor: 3.806

5.  Rates of spontaneous mutation among RNA viruses.

Authors:  J W Drake
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

6.  Highly conserved configuration of catalytic amino acid residues among calicivirus-encoded proteases.

Authors:  Tomoichiro Oka; Mami Yamamoto; Masaru Yokoyama; Satoko Ogawa; Grant S Hansman; Kazuhiko Katayama; Kana Miyashita; Hirotaka Takagi; Yukinobu Tohya; Hironori Sato; Naokazu Takeda
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

7.  Structural insights into mechanisms of catalysis and inhibition in Norwalk virus polymerase.

Authors:  Dmitry F Zamyatkin; Francisco Parra; José M Martín Alonso; Daniel A Harki; Blake R Peterson; Pawel Grochulski; Kenneth K-S Ng
Journal:  J Biol Chem       Date:  2008-01-09       Impact factor: 5.157

8.  Norovirus recombination in ORF1/ORF2 overlap.

Authors:  Rowena A Bull; Grant S Hansman; Leighton E Clancy; Mark M Tanaka; William D Rawlinson; Peter A White
Journal:  Emerg Infect Dis       Date:  2005-07       Impact factor: 6.883

9.  VPg of murine norovirus binds translation initiation factors in infected cells.

Authors:  Katie F Daughenbaugh; Christiane E Wobus; Michele E Hardy
Journal:  Virol J       Date:  2006-05-23       Impact factor: 4.099

10.  Genetic diversity of Sapovirus in children, Australia.

Authors:  Grant S Hansman; Naokazu Takeda; Kazuhiko Katayama; Elise T V Tu; Christopher J McIver; William D Rawlinson; Peter A White
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

View more
  16 in total

Review 1.  Comprehensive review of human sapoviruses.

Authors:  Tomoichiro Oka; Qiuhong Wang; Kazuhiko Katayama; Linda J Saif
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

2.  Nonnucleoside inhibitors of norovirus RNA polymerase: scaffolds for rational drug design.

Authors:  Auda A Eltahla; Kun Lee Lim; John-Sebastian Eden; Andrew G Kelly; Jason M Mackenzie; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

3.  TLR7 Agonists Display Potent Antiviral Effects against Norovirus Infection via Innate Stimulation.

Authors:  Daniel Enosi Tuipulotu; Natalie E Netzler; Jennifer H Lun; Jason M Mackenzie; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

4.  Norovirus RNA synthesis is modulated by an interaction between the viral RNA-dependent RNA polymerase and the major capsid protein, VP1.

Authors:  Chennareddy V Subba-Reddy; Muhammad Amir Yunus; Ian G Goodfellow; C Cheng Kao
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

5.  VPg-primed RNA synthesis of norovirus RNA-dependent RNA polymerases by using a novel cell-based assay.

Authors:  Chennareddy V Subba-Reddy; Ian Goodfellow; C Cheng Kao
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

Review 6.  Recent Advances in the Discovery of Norovirus Therapeutics.

Authors:  Yunjeong Kim; Anushka C Galasiti Kankanamalage; Kyeong-Ok Chang; William C Groutas
Journal:  J Med Chem       Date:  2015-08-17       Impact factor: 7.446

7.  High-resolution functional profiling of the norovirus genome.

Authors:  Lucy Thorne; Dalan Bailey; Ian Goodfellow
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

8.  Antiviral activity of nucleoside analogues against norovirus.

Authors:  Verónica P Costantini; Tony Whitaker; Leslie Barclay; David Lee; Tamara R McBrayer; Raymond F Schinazi; Jan Vinjé
Journal:  Antivir Ther       Date:  2012-08-14

9.  Structural basis for specific recognition of substrates by sapovirus protease.

Authors:  Masaru Yokoyama; Tomoichiro Oka; Hirotatsu Kojima; Tetsuo Nagano; Takayoshi Okabe; Kazuhiko Katayama; Takaji Wakita; Tadahito Kanda; Hironori Sato
Journal:  Front Microbiol       Date:  2012-09-05       Impact factor: 5.640

10.  Novel norovirus recombinants and of GII.4 sub-lineages associated with outbreaks between 2006 and 2010 in Belgium.

Authors:  Elisabeth Mathijs; Sarah Denayer; Leonor Palmeira; Nadine Botteldoorn; Alexandra Scipioni; Alain Vanderplasschen; Etienne Thiry; Katelijne Dierick
Journal:  Virol J       Date:  2011-06-18       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.